Subject to development progress, regulatory approvals, and market priorities, the following expansions are currently planned for the iMOST platform:
Troubleshooting is typically initiated remotely. If hardware service is necessary, support is coordinated through the local distributor or an authorized service partner, adhering to the established service agreement.
No. iMOST is a multi-assay platform; CBC is the first available test.
The analyzer is deemed out of warranty under the following conditions:
After the warranty period ends, Essenlix provides paid technical support, including spare parts and repair or replacement options. Specific duration and coverage details are governed by your applicable commercial agreement and warranty policy.
Q-Cards support room temperature storage (-5°C to 40°C, humidity < 90%)
The iMOST platform is manufactured in Shanghai, China, within ISO 13485–certified facilities. These sites have successfully undergone rigorous audits by global IVD partners.
No. Cloud connectivity is optional. All analysis is performed locally on the device.
Yes. iMOST supports HL7 for direct LIS/HIS integration.
Training is minimal. Remote or online sessions lasting 30 to 60 minutes are typically sufficient for operators. Usability studies confirm that users with limited lab experience can operate the device effectively.
The workflow is designed for maximum simplicity: One Q-Card, one press, one insertion. There is no need for complex sample preparation, dilutions, or multi-step mixing.